Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ANI PHARMACEUTICALS INC
Report date March 29, 2021 · Filed March 30, 2021
Section 16 reporting ended · disclosed 2021-03-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 87,477 |
Reported balance
After 2021-03-29 transaction · row 1
1 source rowRow 1 · 2021-03-29 · Tax withholding · Disposed 5,566 · Balance 87,477 F1: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 16,711 shares of restricted stock, the grant of which was previously reported. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 16,711 shares of restricted stock, the grant of which was previously reported.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2021 Filed Mar 30, 2021 00:11 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 5,566 | $32.68 | $181,896.88 |
DisclosureSEC source: 0001415889-21-001685 · form4-03292021_050311.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - NEW BUS DEV & SPEC SALES 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,477 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 16,711 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| April 10, 2020 Filed Apr 14, 2020 20:32 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 39,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-046393 · tm2015775d2_form4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,043 F1 · kind: The restricted stock vests in four equal annual installments on the first, second, third and fourth anniversaries of April 10, 2020. Read SEC document |
| April 07, 2020 Filed Apr 8, 2020 21:55 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 396 | $43.93 | $17,396.28 |
DisclosureSEC source: 0001104659-20-044731 · tm2015378d4_4.xml · nonDerivative · entry 2 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,276 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,188 shares of restricted stock, which was previously reported. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 21:55 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 666 | $43.22 | $28,784.52 |
DisclosureSEC source: 0001104659-20-044731 · tm2015378d4_4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,672 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,000 shares of restricted stock, which was previously reported. Read SEC document |
| March 31, 2020 Filed Apr 1, 2020 01:40 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 552 | $40.74 | $22,488.48 |
DisclosureSEC source: 0001104659-20-041411 · tm2014433-3_4.xml · nonDerivative · entry 2 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,338 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,656 shares of restricted stock, which was previously reported. Read SEC document |
| March 28, 2020 Filed Apr 1, 2020 01:40 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,037 | $37.76 | $39,157.12 |
DisclosureSEC source: 0001104659-20-041411 · tm2014433-3_4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,890 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,112 shares of restricted stock, which was previously reported. Read SEC document |
| May 13, 2019 Filed May 13, 2019 20:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 2,409 | $71.13 | $171,352.17 |
DisclosureSEC source: 0001144204-19-025603 · tv521454_form4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,927 Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:34 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 360 | $68.60 | $24,696.00 |
DisclosureSEC source: 0001144204-19-020283 · tv519120_form4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,336 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 750 shares of restricted stock, which was previously reported. Read SEC document |
| April 07, 2019 Filed Apr 9, 2019 20:43 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 392 | $70.50 | $27,636.00 |
DisclosureSEC source: 0001144204-19-018900 · tv518453_form4.xml · nonDerivative · entry 2 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,696 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,188 shares of restricted stock, which was previously reported. Read SEC document |
| April 06, 2019 Filed Apr 9, 2019 20:43 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 659 | $70.50 | $46,459.50 |
DisclosureSEC source: 0001144204-19-018900 · tv518453_form4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,088 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,000 shares of restricted stock, which was previously reported. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 20:48 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 546 | $70.54 | $38,514.84 |
DisclosureSEC source: 0001144204-19-017773 · tv517846_4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,747 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,656 shares of restricted stock, which was previously reported. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 20:00 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantStock Options · Derivative | 15,064 | $0.00 Strike: $66.39 | $0.00 |
DisclosureSEC source: 0001144204-19-017403 · tv517656_4.xml · derivative · entry 2 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,064 Underlying: Common Stock · 15,064 shares Expires 2029-03-27 F1 · security: The restricted stock and stock options vest in four equal annual installments on the first, second, third and fourth anniversary of March 28, 2019. F1 · derivative.exercise_date: The restricted stock and stock options vest in four equal annual installments on the first, second, third and fourth anniversary of March 28, 2019. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 20:00 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 12,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-017403 · tv517656_4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,293 F1 · security: The restricted stock and stock options vest in four equal annual installments on the first, second, third and fourth anniversary of March 28, 2019. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 10:02 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionOption to Purchase · Derivative | 4,651 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0001144204-19-013796 · tv516184_form4.xml · derivative · entry 9 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,846 Underlying: Common Stock · 4,651 shares Expires 2024-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option vests and are exercisable over a four year period beginning on the first anniversary of the April 1, 2014. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 10:02 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 4,651 | $64.43 | $299,645.79 |
DisclosureSEC source: 0001144204-19-013796 · tv516184_form4.xml · nonDerivative · entry 6 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,842 Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 10:02 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionCommon Stock | 4,651 | $33.00 | $153,483.00 |
DisclosureSEC source: 0001144204-19-013796 · tv516184_form4.xml · nonDerivative · entry 5 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 10:02 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionOption to Purchase · Derivative | 1,503 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0001144204-19-013796 · tv516184_form4.xml · derivative · entry 8 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,497 Underlying: Common Stock · 1,503 shares Expires 2024-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option vests and are exercisable over a four year period beginning on the first anniversary of the April 1, 2014. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 10:02 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionOption to Purchase · Derivative | 5,642 | $0.00 Strike: $28.76 | $0.00 |
DisclosureSEC source: 0001144204-19-013796 · tv516184_form4.xml · derivative · entry 7 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608 Underlying: Common Stock · Not disclosed shares Expires 2024-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option vests and are exercisable over a four year period beginning on the first anniversary of the August 20, 2014. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 10:02 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 1,503 | $64.50 | $96,943.50 |
DisclosureSEC source: 0001144204-19-013796 · tv516184_form4.xml · nonDerivative · entry 4 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,842 Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 10:02 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionCommon Stock | 1,503 | $33.00 | $49,599.00 |
DisclosureSEC source: 0001144204-19-013796 · tv516184_form4.xml · nonDerivative · entry 3 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 10:02 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 5,642 | $64.44 | $363,578.38 |
DisclosureSEC source: 0001144204-19-013796 · tv516184_form4.xml · nonDerivative · entry 2 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,842 Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 10:02 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionCommon Stock | 5,642 | $28.76 | $162,263.92 |
DisclosureSEC source: 0001144204-19-013796 · tv516184_form4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2018 Filed Sep 14, 2018 20:30 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionOption to Purchase · Derivative | 28,688 | $0.00 Strike: $6.60 | $0.00 |
DisclosureSEC source: 0001144204-18-049518 · tv502903_4.xml · derivative · entry 2 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,688 shares Expires 2023-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option vests over a four year period beginning on the first anniversary of August 1, 2013. Read SEC document |
| September 11, 2018 Filed Sep 14, 2018 20:30 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionCommon Stock | 28,688 | $6.60 | $189,340.80 |
DisclosureSEC source: 0001144204-18-049518 · tv502903_4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,842 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2018 Filed May 24, 2018 20:02 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 600 | $61.88 | $37,128.00 |
DisclosureSEC source: 0001144204-18-030787 · tv494957_form4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,154 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of restricted stock, which was previously reported. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 20:37 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 247 | $60.21 | $14,871.87 |
DisclosureSEC source: 0001144204-18-021180 · tv491304_4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,754 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of restricted stock, which was previously reported. Read SEC document |
| April 07, 2018 Filed Apr 10, 2018 21:21 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 391 | $57.06 | $22,310.46 |
DisclosureSEC source: 0001144204-18-019985 · tv490740_4.xml · nonDerivative · entry 2 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,001 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of restricted stock, which was previously reported. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 21:21 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantStock Options · Derivative | 9,600 | $0.00 Strike: $57.06 | $0.00 |
DisclosureSEC source: 0001144204-18-019985 · tv490740_4.xml · derivative · entry 3 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,600 Underlying: Common Stock · 9,600 shares Expires 2028-04-05 F1 · security: The restricted stock and the stock options vests, and are exercisable, in equal annual installments on the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: The restricted stock and the stock options vests, and are exercisable, in equal annual installments on the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 21:21 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-019985 · tv490740_4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,392 F1 · security: The restricted stock and the stock options vests, and are exercisable, in equal annual installments on the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 21:21 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 546 | $58.22 | $31,788.12 |
DisclosureSEC source: 0001144204-18-019007 · tv490183_form4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,392 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of restricted stock, which was previously reported. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionStock Option · Derivative | 18,750 | $0.00 Strike: $28.76 | $0.00 |
DisclosureSEC source: 0001144204-18-012825 · tv487709_form4.xml · derivative · entry 6 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 18,750 shares Expires 2024-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vest and become exercisable in equal annual amounts over a four-year period beginning on the first anniversary of the grant date. The grant date of the options was August 20, 2014. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 400 | $63.07 | $25,228.00 |
DisclosureSEC source: 0001144204-18-012825 · tv487709_form4.xml · nonDerivative · entry 5 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,938 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 11,954 | $62.25 | $744,136.50 |
DisclosureSEC source: 0001144204-18-012825 · tv487709_form4.xml · nonDerivative · entry 4 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,338 F3 · price: This transaction was executed in multiple trades at prices ranging from $62.00 to $62.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 10,800 | $61.64 | $665,712.00 |
DisclosureSEC source: 0001144204-18-012825 · tv487709_form4.xml · nonDerivative · entry 3 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,292 F2 · price: This transaction was executed in multiple trades at prices ranging from $61.00 to $61.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 5,498 | $60.33 | $331,694.34 |
DisclosureSEC source: 0001144204-18-012825 · tv487709_form4.xml · nonDerivative · entry 2 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,092 F1 · price: This transaction was executed in multiple trades at prices ranging from $60.00 to $60.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionCommon Stock | 18,750 | $28.76 | $539,250.00 |
DisclosureSEC source: 0001144204-18-012825 · tv487709_form4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,590 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2017 Filed May 24, 2017 20:31 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 450 | $47.01 | $21,154.50 |
DisclosureSEC source: 0001144204-17-029347 · v467761_form4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,840 F1 · kind: In accordance with Rule 16b-3, represents shares withheld by the Issuer to satisfy tax withholding obligation upon vesting of a previously reported restricted stock award. Read SEC document |
| April 17, 2017 Filed Apr 18, 2017 20:30 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 270 | $51.22 | $13,829.40 |
DisclosureSEC source: 0001144204-17-020903 · v464425_4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,290 F1 · kind: In accordance with Rule 16b-3, represents shares withheld by the Issuer to satisfy tax withholding obligation upon vesting of a previously reported restricted stock award. Read SEC document |
| April 07, 2017 Filed Apr 11, 2017 20:31 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 427 | $51.24 | $21,879.48 |
DisclosureSEC source: 0001144204-17-020027 · v464044_form4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,560 F1 · kind: In accordance with Rule 16b-3, represents shares withheld by the Issuer to satisfy tax withholding obligation upon vesting of a previously reported restricted stock award. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 22:05 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantStock Options · Derivative | 13,250 | $0.00 Strike: $49.51 | $0.00 |
DisclosureSEC source: 0001144204-17-018957 · v463548_form4.xml · derivative · entry 2 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,250 Underlying: Common Stock · 13,250 shares Expires 2027-03-30 F1 · security: The restricted stock and the stock options vests in equal annual installments on the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 22:05 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantRestricted Stock Units to be settled as Common Stock | 6,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-018957 · v463548_form4.xml · nonDerivative · entry 1 Schrepfer Robert W · CIK 0001579464 · SVP - New Bus Dev & Spec Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,987 F1 · security: The restricted stock and the stock options vests in equal annual installments on the first, second, third and fourth anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.